vs
Side-by-side financial comparison of Inspire Medical Systems, Inc. (INSP) and Regional Management Corp. (RM). Click either name above to swap in a different company.
Inspire Medical Systems, Inc. is the larger business by last-quarter revenue ($204.6M vs $167.3M, roughly 1.2× Regional Management Corp.). On growth, Regional Management Corp. posted the faster year-over-year revenue change (9.4% vs 1.6%). Over the past eight quarters, Regional Management Corp.'s revenue compounded faster (8.2% CAGR vs 2.2%).
Inspire Medical Systems, Inc. is a medical technology firm that develops, manufactures and commercializes implantable neurostimulation solutions for obstructive sleep apnea. Its core product serves patients intolerant to CPAP therapy, with main markets across North America, Europe, and select Asia-Pacific regions, operating in sleep medicine and otolaryngology segments.
Millennium Management LLC is an investment management firm with a multistrategy hedge fund offering. It is one of the world's largest alternative asset management firms with $83.4 billion assets under management as of January 2026. The firm operates in America, Europe and Asia. As of 2022, Millennium had posted the fourth highest net gains of any hedge fund since its inception in 1989.
INSP vs RM — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $204.6M | $167.3M |
| Net Profit | — | $11.4M |
| Gross Margin | 86.5% | — |
| Operating Margin | 13.0% | — |
| Net Margin | — | 6.8% |
| Revenue YoY | 1.6% | 9.4% |
| Net Profit YoY | — | 62.7% |
| EPS (diluted) | $-0.39 | $1.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $204.6M | $167.3M | ||
| Q4 25 | $269.1M | $169.7M | ||
| Q3 25 | $224.5M | $165.5M | ||
| Q2 25 | $217.1M | $157.4M | ||
| Q1 25 | $201.3M | $153.0M | ||
| Q4 24 | $239.7M | $154.8M | ||
| Q3 24 | $203.2M | $146.3M | ||
| Q2 24 | $195.9M | $143.0M |
| Q1 26 | — | $11.4M | ||
| Q4 25 | $136.1M | $12.9M | ||
| Q3 25 | $9.9M | $14.4M | ||
| Q2 25 | $-3.6M | $10.1M | ||
| Q1 25 | $3.0M | $7.0M | ||
| Q4 24 | $35.2M | $9.9M | ||
| Q3 24 | $18.5M | $7.7M | ||
| Q2 24 | $9.8M | $8.4M |
| Q1 26 | 86.5% | — | ||
| Q4 25 | 86.6% | — | ||
| Q3 25 | 85.8% | — | ||
| Q2 25 | 84.0% | — | ||
| Q1 25 | 84.7% | — | ||
| Q4 24 | 85.0% | — | ||
| Q3 24 | 84.1% | — | ||
| Q2 24 | 84.8% | — |
| Q1 26 | 13.0% | — | ||
| Q4 25 | 17.1% | 9.5% | ||
| Q3 25 | 4.3% | 11.5% | ||
| Q2 25 | -1.5% | 8.6% | ||
| Q1 25 | -0.7% | 6.0% | ||
| Q4 24 | 13.3% | 8.2% | ||
| Q3 24 | 7.0% | 6.9% | ||
| Q2 24 | 2.6% | 7.8% |
| Q1 26 | — | 6.8% | ||
| Q4 25 | 50.6% | 7.6% | ||
| Q3 25 | 4.4% | 8.7% | ||
| Q2 25 | -1.7% | 6.4% | ||
| Q1 25 | 1.5% | 4.6% | ||
| Q4 24 | 14.7% | 6.4% | ||
| Q3 24 | 9.1% | 5.2% | ||
| Q2 24 | 5.0% | 5.9% |
| Q1 26 | $-0.39 | $1.18 | ||
| Q4 25 | $4.57 | $1.30 | ||
| Q3 25 | $0.34 | $1.42 | ||
| Q2 25 | $-0.12 | $1.03 | ||
| Q1 25 | $0.10 | $0.70 | ||
| Q4 24 | $1.17 | $0.96 | ||
| Q3 24 | $0.60 | $0.76 | ||
| Q2 24 | $0.32 | $0.86 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $98.9M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $792.3M | $375.8M |
| Total Assets | $911.4M | $2.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $98.9M | — | ||
| Q4 25 | $308.3M | — | ||
| Q3 25 | $322.6M | — | ||
| Q2 25 | $300.9M | — | ||
| Q1 25 | $369.2M | — | ||
| Q4 24 | $445.5M | — | ||
| Q3 24 | $411.0M | — | ||
| Q2 24 | $439.7M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | $1.6B | ||
| Q3 25 | — | $1.6B | ||
| Q2 25 | — | $1.5B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | $1.4B | ||
| Q2 24 | — | $1.4B |
| Q1 26 | $792.3M | $375.8M | ||
| Q4 25 | $781.2M | $373.1M | ||
| Q3 25 | $666.5M | $371.9M | ||
| Q2 25 | $677.8M | $363.0M | ||
| Q1 25 | $635.7M | $357.9M | ||
| Q4 24 | $689.7M | $357.1M | ||
| Q3 24 | $696.6M | $352.9M | ||
| Q2 24 | $638.1M | $344.9M |
| Q1 26 | $911.4M | $2.1B | ||
| Q4 25 | $907.3M | $2.1B | ||
| Q3 25 | $807.7M | $2.0B | ||
| Q2 25 | $802.2M | $2.0B | ||
| Q1 25 | $730.8M | $1.9B | ||
| Q4 24 | $808.4M | $1.9B | ||
| Q3 24 | $796.2M | $1.8B | ||
| Q2 24 | $728.4M | $1.8B |
| Q1 26 | — | — | ||
| Q4 25 | — | 4.40× | ||
| Q3 25 | — | 4.23× | ||
| Q2 25 | — | 4.14× | ||
| Q1 25 | — | 4.11× | ||
| Q4 24 | — | 4.12× | ||
| Q3 24 | — | 3.94× | ||
| Q2 24 | — | 3.98× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
